Stivarga 40 mg

STIVARGA 40 MG tablets are a prescription medication used for specific cancer treatments. This oral medication is designed to target certain types of cancer cells, offering a therapeutic option for patients.

STIVARGA 40 MG tablets are primarily used in the treatment of advanced cancers. Regorafenib, the active ingredient, is often prescribed for patients who have limited treatment options. The medication works by inhibiting the growth of cancer cells, providing a potential therapeutic benefit for those with specific types of cancer.

Common effects of STIVARGA 40 MG tablets may include fatigue, diarrhea, and hand-foot skin reaction. Some patients may also experience appetite loss, weight loss, and high blood pressure. These effects can vary from person to person, and it is important to consult with a healthcare provider for personalized advice.

STIVARGA 40 MG tablets should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should be aware of potential side effects and discuss any concerns with their healthcare provider.

STIVARGA 40 MG tablets may interact with certain medications, including those that are metabolized by the liver. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect the efficacy and safety of this medication.